Delivery Order SPE2DB20D1109-SPE2DB22FP35F
Award Date
6/2/22
Potential Completion Date
6/3/22
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $1,057 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The $9,845.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet medication to the Defense Logistics Agency (DLA). The $2,494.96 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Micardis HCT 80-12.5 mg tablet units. The award, valued at $6,060.65, is a firm fixed-price delivery order contract with a completion date of March 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,224.79 delivery order contract is a firm fixed-price agreement for the supply of 4563018964 units of Micardis HCT 80-25 mg tablets. The contract has an ultimate completion date of December 7, 2023 and was awarded on December 6, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,074.50 and an ultimate completion date of May 7, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award, valued at $2,101.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award provides for the delivery of Micardis HCT 80-25 mg tablet units, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of January 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. This $7,010.86 delivery order was awarded on April 27, 2023, with a completion date of April 28, 2023. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition....
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,346.30 and a final completion date of December 5, 2023. It is a delivery order contract with a firm fixed price pricing type. This contract is not designated with any set-aside requirements,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,301.18 for the supply of Micardis HCT 80-25 mg tablet medication. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of January 27, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...